Season 25 Episode 143
Dr Aaron Lisberg from the University of California, Los Angeles, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer.
CME information and select publications here.
Published on 19 hours ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate